DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Orchard TR, van der Geest SA, Travis SP.
Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis – new light on a familiar question.
Aliment Pharmacol Ther 2011;
33: 1028-1035
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.